Detalhe da pesquisa
1.
Sex Differences in Low-Density Lipoprotein Cholesterol Reduction With PCSK9 Inhibitors in Real-world Patients: The LIPID-REAL Registry.
J Cardiovasc Pharmacol
; 79(4): 523-529, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34983910